Brief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
28/05/2026 06:46
BRIEF-NextCell Pharma Q1 Operating Income At SEK 2.8 Million May 28 (Reuters) - NextCell Pharma AB NXTCL.ST:
Q1 OPERATING INCOME AMOUNTED TO SEK 2.8 MILLION
Q1 NET SALES AMOUNTED TO SEK 2.7 MILLION, CELLAVIVA CONTRIBUTED SEK 2.6 MILLION
Q1 PROFIT/LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -10.4 MILLION
Source text: ID:nWkrc5c4fX
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Updates On Timing Of ProTrans-Young Results
Brief: Nextcell Pharma Q2 2026 Operating Income SEK 3.0 Mln
Brief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation